PTPRF as a novel tumor suppressor through deactivation of ERK1/2 signaling in gastric adenocarcinoma.

Onco Targets Ther · 2018 · PMC6223389 · PMID 30464527

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP =0.070so close (0.05 < p ≤ 0.1)

Additionally, patients with larger tumors also exhibited lower PTPRF levels, though this did not reach statistical significance ( P =0.070).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.